Guselkumab for previously treated moderately to severely active Crohn's disease ID6238

In development
Reference number: GID-TA11245
Expected publication date: 28 August 2025

Register as a stakeholder

Documents

Documents created during the development process.

Invitation to participate

Final stakeholder list (PDF 169 KB)

Published:

14 January 2025
Final scope (PDF 150 KB)

Published:

14 January 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 172 KB)

Published:

14 January 2025
Equality impact assessment (scoping) (PDF 103 KB)

Published:

14 January 2025

Invitation to participate

Final scope (PDF 186 KB)

Published:

30 July 2024
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 226 KB)

Published:

30 July 2024
Provisional stakeholder list (post-referral) (PDF 169 KB)

Published:

30 July 2024
Equality impact assessment (scoping) (PDF 129 KB)

Published:

30 July 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6238

Draft matrix post referral (PDF 168 KB)

Published:

07 May 2024
Draft scope post referral (PDF 208 KB)

Published:

07 May 2024